Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2025 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2025 Earnings Call Transcript November 5, 2025

Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.935, expectations were $0.05.

Operator: Good day, everyone, and thank you for standing by. My name is RG, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q3 2025 Seres Therapeutics Results and Business Updates. [Operator Instructions] Thank you. I would now like to turn the call...